World Rare Disease Day - Let’s Talk SMA Screening
Release Date 2025-02-28

This #WorldRareDiseaseDay, Let’s Talk SMA Screening – Every Child Deserves a Healthy Start!

Did you know? Spinal Muscular Atrophy (SMA) is a rare genetic disorder that affects approximately 1 in 10,000 newborns globally, though rates vary across populations, leading to muscle weakness and life-threatening complications. But here’s the good news: early screening can change lives.  

微信图片_20231120113859.jpg

Tianlong’s Human Survival Motor Neuron 1 (SMN1) Gene Detection Kit – a breakthrough tool designed to:  

✅ Screen for SMN1 gene carriers (helping families understand their genetic risks).  

✅ Aid healthcare professionals in timely SMA diagnosis for early intervention.  

✅ Reduce the risk of birth defects by empowering informed family planning.  

Why does SMA screening matter?

About 1 in 50 individuals worldwide are carriers of SMA-related SMN1 gene mutations. Early detection isn’t just about diagnosis—it’s about prevention. By identifying carriers and supporting timely care, we can protect future generations and give every child the chance to thrive.

This #WorldRareDiseaseDay, join us in raising awareness about SMA. Share this post, together, we can turn science into action.

Share
Recommendation